Savior LLC’s Abiomed Inc ABMD Stock Holding History

Savior LLC’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-21	Closed	-$3K	–	882
2020 Q1	$3K	Hold	21	–	–	﹤0.01%	595
2019 Q4	$4K	Buy	+21	New	+$3.89K	0.01%	656

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Savior LLC's ABMD Position: Q2 2020 in Review

Savior LLC sold out of Abiomed Inc (ABMD) in Q2 2020, closing a stake of 21 shares — an estimated $3K sold.

Savior LLC first reported a position in ABMD in Q4 2019 and held it in 2 quarters. The position peaked at $4K in Q4 2019. 460 funds tracked by Wall St. Rank hold ABMD as of Q2 2020.

Savior LLC reported no remaining Abiomed Inc position as of Q2 2020 after selling out during the quarter.
Savior LLC sold 21 Abiomed Inc shares in Q2 2020, an estimated $3K.
Savior LLC first reported a position in Abiomed Inc in Q4 2019 and held it in 2 quarters.
Savior LLC's Abiomed Inc position peaked at $4K in Q4 2019.
460 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2020.

Based on Savior LLC's 13F filing for Q2 2020, filed 28 Jul 2020.